Reagent Test Strips for Blood
Recall Z-1834-2024, part of FDA recall event 94454. See Macherey-Nagel's company page.
Macherey Nagel Gmbh & Co. Kg started this Class II device recall on Apr 4, 2024 (voluntary: firm initiated); FDA lists it as ongoing.
- Classification: Class II
- Started: Apr 4, 2024
- Status: Ongoing
The reason for the recall is one of the test pads, for the parameter leukocytes, was missing on some of the test strips. The issue was identified by a consumer by way of a Henry Schein Inc. (HSI) customer complaint. This problem can potentially result in the possibility that the parameter leucocytes (a non-specific marker for urinary track infections and an indicator for inflammatory renal processes) is interpreted instrumentally as a false negative. The following HSI item number and lot number were affected: Urispec¿ 11-Way, #102-2285, LOT 65402.
- Product
- Reagent Test Strips for Blood, Urobilinogen, Bilirubin, Protein, Nitrite, Ketones, Ascorbic Acid, Glucose, pH, Specific Gravity and Leucocytes in Urine by the Dip and Read Technique.
- Quantity
- 5,200 packages
- Lots and codes
- Product #102-2285, UDI/DI: 00304040001479, LOT 65402.
- Distribution
- US Nationwide distribution in the states of CO, FL, IN, NV, TX.
- Recalling firm
- Macherey Nagel Gmbh & Co. Kg, Duren, N/A, Germany
- How the firm notified
- Letter
- FDA classified
- May 16, 2024
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports